Trial intelligence / Profile preview

ORCA risperidone discontinuation trial in children and adolescents

NL-OMON20175Phase 4Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risperidone in behavioral disorder, sponsored by University Medical Center Groningen. Started Jan 2016; status: active, not recruiting.

02

Drugs

risperidone
03

Conditions

behavioral disorder

Beyond the preview

Go deeper on NL-OMON20175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call